MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES Read more about MULTIVALENT VACCINES FOR RABIES VIRUS AND CORONAVIRUSES US Application 17/307,066Filed on 2021-05-04
CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS Read more about CONSTRUCTION OF WEST NILE VIRUS AND DENGUE VIRUS CHIMERAS FOR USE IN A LIVE VIRUS VACCINE TO PREVENT DISEASE CAUSED BY WEST NILE VIRUS Australia2021203089Filed on 2021-05-14
RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE Read more about RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE US Patent 11,786,591Filed on 2021-05-18
Development Of Dengue Virus Vaccine Components Read more about Development Of Dengue Virus Vaccine Components Australia2021202950Filed on 2021-05-10
RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS Read more about RSV VACCINE BEARING ONE OF MORE P GENE MUTATIONS Patent Cooperation TreatyPCT/US2021/32305Filed on 2021-05-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Italy15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use United Kingdom15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use France15797815.6Filed on 2015-11-13
Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Read more about Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use Germany15797815.6Filed on 2015-11-13
Modified Anthrax Toxin Protective Antigen Read more about Modified Anthrax Toxin Protective Antigen United Kingdom16767065.2Filed on 2018-03-27